Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 04, 2025 14:46 ET | Source: Robbins LLP

TLX Class Action Reminder: Telix Pharmaceuticals Ltd. Stockholders Should Contact Robbins LLP for Information About Leading the Class Action Against TLX

TLX Class Action Reminder: Telix Pharmaceuticals Ltd. Stockholders Should Contact Robbins LLP for Information About Leading the Class Action Against TLX
November 25, 2025 15:43 ET | Source: Robbins LLP

SKYE Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the Skye Bioscience, Inc. Class Action Lawsuit

SKYE Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the Skye Bioscience, Inc. Class Action Lawsuit
November 20, 2025 13:51 ET | Source: Robbins LLP

PRGO Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Perrigo Company plc Class Action

Robbins LLP is Investigating Allegations that Perrigo Company plc (PRGO) Misled Investors Regarding the Value of its Infant Formula Business
November 18, 2025 14:50 ET | Source: Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Telix Pharmaceuticals Ltd. Securities Class Action

Robbins LLP is Investigating Allegations That Telix Pharmaceuticals Ltd. (TLX) Mislead Investors Regarding its Prostate Cancer Therapeutic Candidates
August 18, 2025 17:56 ET | Source: Robbins LLP

Robbins LLP Reminds Sarepta Therapeutics, Inc. Stockholders of the Pending Lead Plaintiff Deadline in the Securities Class Action Against SRPT

Robbins LLP is Investigating Allegations that Sarepta Therapeutics, Inc. (SRPT) Mislead Investors Regarding the Safety its ELEVIDYS Drug
August 14, 2025 19:25 ET | Source: Robbins LLP

Robbins LLP Urges NVO Stockholders with Large Losses to Contact the Firm for Information about Leading the Class Action Against Novo Nordisk A/S

Robbins LLP is Investigating Allegations that Novo Nordisk A/S (NVO) Misled the Market About its 2025 Revenue and Profit Growth Potential
July 25, 2025 15:22 ET | Source: Robbins LLP

BHVN Class Action Alert: Robbins LLP Reminds Biohaven Ltd. Stockholders of the Lead Plaintiff Deadline in the Class Action Against BHVN

Robbins LLP is Investigating Allegations that Biohaven Ltd. (BHVN) Misled Investors Regarding the Viability of its Candidate
July 21, 2025 17:36 ET | Source: Robbins LLP

BHVN Class Action Alert: Robbins LLP Reminds Biohaven Ltd. Stockholders of the Lead Plaintiff Deadline in the Class Action Against BHVN

Robbins LLP is Investigating Allegations that Biohaven Ltd. (BHVN) Misled Investors Regarding the Viability of its Candidates
July 03, 2025 19:41 ET | Source: Robbins LLP

Robbins LLP Urges HIMS Stockholders with Large Losses to Contact the Firm for Information About the Class Action Pending Against Hims & Hers Health, Inc.

Robbins LLP is Investigating Allegations that Hims & Hers Health, Inc. (HIMS) Deceptively Promoted and Sold Illegitimate Versions of Wegovy®
June 30, 2025 20:34 ET | Source: Robbins LLP

URGN Stock News: Robbins LLP Reminds UroGen Pharma Ltd. Investors of the Pending Lead Plaintiff Deadline in the URGN Class Action – Contact Robbins LLP Before July 28 for Information

Robbins LLP is Investigating Allegations that UroGen Pharma Ltd. (URGN) Failed to Conduct a Proper Trial for its Lead Drug Candidate